Philadelphia Trust Company’s Frontline FRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$495K Sell
14,199
-4,899
-26% -$150K 0.03% 160
2025
Q4
$417K Sell
19,098
-875
-4% -$20.5K 0.03% 174
2025
Q3
$455K Sell
19,973
-444
-2% -$8.99K 0.03% 164
2025
Q2
$335K Sell
20,417
-1,010
-5% -$17.1K 0.03% 188
2025
Q1
$318K Buy
21,427
+5,200
+32% +$86K 0.03% 195
2024
Q4
$230K Hold
16,227
0.02% 220
2024
Q3
$371K Buy
16,227
+1,000
+7% +$23.5K 0.03% 186
2024
Q2
$392K Hold
15,227
0.03% 161
2024
Q1
$356K Buy
15,227
+875
+6% +$19.7K 0.03% 172
2023
Q4
$288K Sell
14,352
-5,036
-26% -$104K 0.03% 185
2023
Q3
$364K Hold
19,388
0.04% 167
2023
Q2
$282K Hold
19,388
0.03% 190
2023
Q1
$321K Buy
+19,388
New +$305K 0.03% 181

Other funds holding FRO

Philadelphia Trust Company's FRO Position: Q1 2026 in Review

Philadelphia Trust Company reduced its Frontline (FRO) stake by 26% in Q1 2026, selling an estimated $150K and leaving 14,199 shares worth $495K. The position accounts for 0.03% of the portfolio, ranked #160.

Philadelphia Trust Company first reported a position in FRO in Q1 2023 and has held it in 13 quarters since. 239 funds tracked by Wall St. Rank hold FRO as of Q1 2026.

  • Philadelphia Trust Company held 14,199 shares of Frontline worth $495K as of Q1 2026.
  • Philadelphia Trust Company sold 4,899 Frontline shares in Q1 2026, an estimated $150K.
  • Frontline made up 0.03% of Philadelphia Trust Company's portfolio in Q1 2026, its #160 holding.
  • Philadelphia Trust Company first reported a position in Frontline in Q1 2023 and has held it in 13 quarters since.
  • 239 funds tracked by Wall St. Rank held Frontline as of Q1 2026.

Based on Philadelphia Trust Company's 13F filing for Q1 2026, filed 13 May 2026.